Mark Plavsic - Chief Technical Officer at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technical Officer
Stock Symbol
FATE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Plavsic since 7/8/2023

Holdings reported by Mark Plavsic for Fate Therapeutics Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 123,705 $541 K $4.37 Jan 10, 2023 Direct
Stock Option (Right to Buy) 53,058 $145 K $2.73 Jan 25, 2022 Direct Common Stock

Transactions reported by Mark Plavsic for Fate Therapeutics Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership